Business Description
Biogen is a global biopharmaceutical company founded in 1978 and based in Cambridge, Massachusetts, focused on developing and delivering treatments for serious neurological and rare diseases, including multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and several other conditions. The company markets a broad portfolio of medicines and biosimilars across the United States, Europe, Asia, and beyond. Biogen works alongside a network of partners and collaborators to advance new therapies, including treatments for Dravet syndrome and other conditions that currently have few or no options available to patients.
